Skip to content

Modified Oscor Py Pacing Leads/Modification

by Oscor Medical Corp.

510(k) K913158

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK913158 Date23 Sep 1991ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Modified Oscor PY Pacing Leads are classified as Permanent Pacemaker Electrodes, designed for use in cardiac pacing systems. These leads deliver electrical impulses to stimulate the heart, ensuring proper rhythm and function in patients requiring pacemaker therapy.

These leads are intended for single-use and are supplied sterile for direct implantation during cardiac procedures. They are regulated under FDA 510K clearance (K913158) and fall under device classification DTB, adhering to regulatory standards for cardiovascular devices. Multiple reference codes (e.g., 3002618605, 1028232) identify variations in lead specifications, ensuring compatibility with various pacemaker systems.

Other devices from Oscor Medical Corp.

See all devices from Oscor Medical Corp. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are these pacing leads designed for reuse in multiple patients, or are they intended for single-use only?

    These Modified Oscor PY Pacing Leads are explicitly intended for single-use only and are supplied sterile for direct implantation. The device description and FDA 510K submission emphasize their sterile packaging and intended use in a single cardiac procedure to ensure patient safety and compliance with medical device standards.

  • What types of pacemaker systems are these leads compatible with, and how do I determine the correct model for my patient?

    These leads are designed for compatibility with various pacemaker systems, as indicated by the multiple OpenFDA reference codes (e.g., 3002618605, 1028232, etc.). To select the correct model, verify the specific lead specifications (e.g., electrode type, coil configuration, or connector size) against your pacemaker system’s requirements. The manufacturer’s documentation or a clinical specialist can assist in matching the right lead to your patient’s device.

  • How should these leads be stored before use, and what precautions should be taken to maintain sterility?

    Since these leads are sterile upon packaging, they must be stored in their original, unopened packaging to preserve sterility. The packaging should be kept in a clean, dry environment away from direct sunlight or extreme temperatures. Avoid contamination by ensuring the sterile barrier is intact until immediate pre-procedure preparation. Always follow the manufacturer’s storage guidelines to prevent degradation or compromise of sterility.

  • What regulatory pathway was followed for FDA clearance of these leads, and what does that mean for clinical use?

    These leads were cleared through the FDA 510K pathway (K913158), specifically under the Traditional review process with a Substantially Equivalent (SESE) determination. This means the device was compared to a legally marketed predicate and deemed equivalent in safety and effectiveness for its intended use as a permanent pacemaker electrode. Clinically, this clearance confirms the leads meet FDA standards for cardiac pacing applications, but always verify compatibility with your facility’s protocols and the specific pacemaker system in use.